This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
TRA-1-60 Antibody, clone TRA-1-60, FITC conjugate
catalog :
FCMAB115F
quantity :
100 tests
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
TRA-1-60

The same clone is also sold as:
reactivity :
human
application :
immunocytochemistry, flow cytometry
citations: 184
Published Application/Species/Sample/DilutionReference
  • flow cytometry; human
  • immunocytochemistry; human; loading ...; fig 6b
Neganova I, Chichagova V, Armstrong L, Lako M. A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs. Sci Rep. 2017;7:41693 pubmed publisher
  • flow cytometry; human; 1:200; loading ...; fig 1b
Zhu L, Gómez Durán A, Saretzki G, Jin S, Tilgner K, Melguizo Sanchís D, et al. The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages. J Cell Biol. 2016;215:187-202 pubmed
  • flow cytometry; human; loading ...; fig 1c
Long Y, Xu M, Li R, Dai S, Beers J, Chen G, et al. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A. Stem Cells Transl Med. 2016;5:1644-1655 pubmed
  • flow cytometry; human; fig 4
Miki T, Wong W, Zhou E, Gonzalez A, Garcia I, Grubbs B. Biological impact of xeno-free chemically defined cryopreservation medium on amniotic epithelial cells. Stem Cell Res Ther. 2016;7:8 pubmed publisher
  • flow cytometry; human
Beers J, Linask K, Chen J, Siniscalchi L, Lin Y, Zheng W, et al. A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci Rep. 2015;5:11319 pubmed publisher
Buskin A, Zhu L, Chichagova V, Basu B, Mozaffari Jovin S, Dolan D, et al. Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa. Nat Commun. 2018;9:4234 pubmed publisher
Ihry R, Worringer K, Salick M, Frias E, Ho D, Theriault K, et al. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med. 2018;24:939-946 pubmed publisher
Melguizo Sanchís D, Xu Y, Taheem D, Yu M, Tilgner K, Bárta T, et al. iPSC modeling of severe aplastic anemia reveals impaired differentiation and telomere shortening in blood progenitors. Cell Death Dis. 2018;9:128 pubmed publisher
Shukla V, Rao M, ZHANG H, Beers J, Wangsa D, Wangsa D, et al. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer. Cancer Res. 2017;77:6267-6281 pubmed publisher
Cerbini T, Funahashi R, Luo Y, Liu C, Park K, Rao M, et al. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. PLoS ONE. 2015;10:e0116032 pubmed publisher
Byrne S, Ortiz L, Mali P, Aach J, Church G. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43:e21 pubmed publisher
Afanassieff M, Tapponnier Y, Savatier P. Generation of Induced Pluripotent Stem Cells in Rabbits. Methods Mol Biol. 2016;1357:149-72 pubmed publisher
Turner J, Quek L, Titmarsh D, Krömer J, Kao L, Nielsen L, et al. Metabolic profiling and flux analysis of MEL-2 human embryonic stem cells during exponential growth at physiological and atmospheric oxygen concentrations. PLoS ONE. 2014;9:e112757 pubmed publisher
Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, et al. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture. PLoS ONE. 2014;9:e112900 pubmed publisher
Tano K, Yasuda S, Kuroda T, Saito H, Umezawa A, Sato Y. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. PLoS ONE. 2014;9:e110496 pubmed publisher
Wattanapanitch M, Klincumhom N, Potirat P, Amornpisutt R, Lorthongpanich C, U Pratya Y, et al. Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages. PLoS ONE. 2014;9:e106952 pubmed publisher
Ma X, Li H, Xin S, Ma Y, Ouyang T. Human amniotic fluid stem cells support undifferentiated propagation and pluripotency of human embryonic stem cell without b-FGF in a density dependent manner. Int J Clin Exp Pathol. 2014;7:4661-73 pubmed
Qian X, Villa Diaz L, Kumar R, Lahann J, Krebsbach P. Enhancement of the propagation of human embryonic stem cells by modifications in the gel architecture of PMEDSAH polymer coatings. Biomaterials. 2014;35:9581-90 pubmed publisher
Jha B, Rao M, Malik N. Motor neuron differentiation from pluripotent stem cells and other intermediate proliferative precursors that can be discriminated by lineage specific reporters. Stem Cell Rev. 2015;11:194-204 pubmed publisher
Erogullari A, Hollstein R, Seibler P, Braunholz D, Koschmidder E, Depping R, et al. THAP1, the gene mutated in DYT6 dystonia, autoregulates its own expression. Biochim Biophys Acta. 2014;1839:1196-204 pubmed publisher
Higashi K, Asano K, Yagi M, Yamada K, Arakawa T, Ehashi T, et al. Expression of the clustered NeuAc?2-3Gal? O-glycan determines the cell differentiation state of the cells. J Biol Chem. 2014;289:25833-43 pubmed publisher
Mehta A, Verma V, Nandihalli M, Ramachandra C, Sequiera G, Sudibyo Y, et al. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells. PLoS ONE. 2014;9:e103485 pubmed publisher
Iovino S, Burkart A, Kriauciunas K, Warren L, Hughes K, Molla M, et al. Genetic insulin resistance is a potent regulator of gene expression and proliferation in human iPS cells. Diabetes. 2014;63:4130-42 pubmed publisher
Kobayashi J, Yoshida M, Tarui S, Hirata M, Nagai Y, Kasahara S, et al. Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome. PLoS ONE. 2014;9:e102796 pubmed publisher
Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park T, et al. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev. 2014;23:2996-3010 pubmed publisher
Jiang G, Di Bernardo J, Maiden M, Villa Diaz L, Mabrouk O, Krebsbach P, et al. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy. Stem Cells Dev. 2014;23:2613-25 pubmed publisher
Mehta A, Ramachandra C, Sequiera G, Sudibyo Y, Nandihalli M, Yong P, et al. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochim Biophys Acta. 2014;1843:2394-402 pubmed publisher
Park M, Park J, Kim M, Lee K, Park H, Yun J, et al. Development of a high-yield technique to isolate spermatogonial stem cells from porcine testes. J Assist Reprod Genet. 2014;31:983-91 pubmed publisher
Grunseich C, Zukosky K, Kats I, Ghosh L, Harmison G, Bott L, et al. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol Dis. 2014;70:12-20 pubmed publisher
Heng B, Fussenegger M. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification. Methods Mol Biol. 2014;1151:75-94 pubmed publisher
Sterthaus O, Feutz A, Zhang H, Pletscher F, Bruder E, Miny P, et al. Gene expression profiles of similarly derived human embryonic stem cell lines correlate with their distinct propensity to exit stemness and their different differentiation behavior in culture. Cell Reprogram. 2014;16:185-95 pubmed publisher
Panicker L, Miller D, Awad O, Bose V, Lun Y, Park T, et al. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development. Stem Cells. 2014;32:2338-49 pubmed publisher
Uh K, Park C, Choi K, Park J, Jeong Y, Roh S, et al. Analysis of imprinted IGF2/H19 gene methylation and expression in normal fertilized and parthenogenetic embryonic stem cells of pigs. Anim Reprod Sci. 2014;147:47-55 pubmed publisher
Higuchi T, Kawagoe S, Otsu M, Shimada Y, Kobayashi H, Hirayama R, et al. The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-?-glucosidase in Pompe's iPSCs. Mol Genet Metab. 2014;112:44-8 pubmed publisher
Yang D, Wang X, Ismail A, Ashman C, Valori C, Wang G, et al. PTEN regulates AMPA receptor-mediated cell viability in iPS-derived motor neurons. Cell Death Dis. 2014;5:e1096 pubmed publisher
Nie Y, Walsh P, Clarke D, Rowley J, Fellner T. Scalable passaging of adherent human pluripotent stem cells. PLoS ONE. 2014;9:e88012 pubmed publisher
Yamasaki S, Taguchi Y, Shimamoto A, Mukasa H, Tahara H, Okamoto T. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-?1 regulation of pluripotency. PLoS ONE. 2014;9:e87151 pubmed publisher
Jiang G, Di Bernardo J, DeLong C, Monteiro da Rocha A, O Shea K, Kunisaki S. Induced pluripotent stem cells from human placental chorion for perinatal tissue engineering applications. Tissue Eng Part C Methods. 2014;20:731-40 pubmed publisher
Mallon B, Hamilton R, Kozhich O, Johnson K, Fann Y, Rao M, et al. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res. 2014;12:376-86 pubmed publisher
Goyal A, CHAVEZ S, Reijo Pera R. Generation of human induced pluripotent stem cells using epigenetic regulators reveals a germ cell-like identity in partially reprogrammed colonies. PLoS ONE. 2013;8:e82838 pubmed publisher
Bhise N, Wahlin K, Zack D, Green J. Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells. Int J Nanomedicine. 2013;8:4641-58 pubmed publisher
Miyazaki T, Nakatsuji N, Suemori H. Optimization of slow cooling cryopreservation for human pluripotent stem cells. Genesis. 2014;52:49-55 pubmed publisher
Cho Y, Han K, Kim D, Lee J, Lee S, Choi K, et al. Autophagy regulates homeostasis of pluripotency-associated proteins in hESCs. Stem Cells. 2014;32:424-35 pubmed publisher
Vuoristo S, Toivonen S, Weltner J, Mikkola M, Ustinov J, Trokovic R, et al. A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation. PLoS ONE. 2013;8:e76205 pubmed publisher
Wang J, Gu Q, Hao J, Bai D, Liu L, Zhao X, et al. Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells. Genomics Proteomics Bioinformatics. 2013;11:304-11 pubmed publisher
Li W, Wei Y, Li H, Lai D, Lin T. Isolation and characterization of a novel strain of mesenchymal stem cells from mouse umbilical cord: potential application in cell-based therapy. PLoS ONE. 2013;8:e74478 pubmed publisher
Choi K, Park J, Kim H, Uh K, Son D, Lee C. Epigenetic changes of lentiviral transgenes in porcine stem cells derived from embryonic origin. PLoS ONE. 2013;8:e72184 pubmed publisher
Tobias I, Brooks C, Teichroeb J, Betts D. Derivation and culture of canine embryonic stem cells. Methods Mol Biol. 2013;1074:69-83 pubmed publisher
Hynes K, Menicanin D, Han J, Marino V, Mrozik K, Gronthos S, et al. Mesenchymal stem cells from iPS cells facilitate periodontal regeneration. J Dent Res. 2013;92:833-9 pubmed publisher
Yang H, Liu Z, Ma Y, Zhong C, Yin Q, Zhou C, et al. Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes. Cell Res. 2013;23:1187-200 pubmed publisher
Ye L, Muench M, Fusaki N, Beyer A, Wang J, Qi Z, et al. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med. 2013;2:558-66 pubmed publisher
Yang G, Mai Q, Li T, Zhou C. Derivation of human embryonic stem cell lines from single blastomeres of low-quality embryos by direct plating. J Assist Reprod Genet. 2013;30:953-61 pubmed publisher
Titmarsh D, Ovchinnikov D, Wolvetang E, Cooper White J. Full factorial screening of human embryonic stem cell maintenance with multiplexed microbioreactor arrays. Biotechnol J. 2013;8:822-34 pubmed publisher
Kawagoe S, Higuchi T, Otaka M, Shimada Y, Kobayashi H, Ida H, et al. Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp). Mol Genet Metab. 2013;109:386-9 pubmed publisher
Chen Y, Wang K, Chandramouli G, Knott J, Leach R. Trophoblast lineage cells derived from human induced pluripotent stem cells. Biochem Biophys Res Commun. 2013;436:677-84 pubmed publisher
Heneidi S, Simerman A, Keller E, Singh P, Li X, Dumesic D, et al. Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS ONE. 2013;8:e64752 pubmed publisher
Noguchi M, Hosoda K, Nakane M, Mori E, Nakao K, Taura D, et al. In vitro characterization and engraftment of adipocytes derived from human induced pluripotent stem cells and embryonic stem cells. Stem Cells Dev. 2013;22:2895-905 pubmed publisher
Hunt M, Meng G, Rancourt D, Gates I, Kallos M. Factorial experimental design for the culture of human embryonic stem cells as aggregates in stirred suspension bioreactors reveals the potential for interaction effects between bioprocess parameters. Tissue Eng Part C Methods. 2014;20:76-89 pubmed publisher
Cao J, Ng E, McNaughton D, Stanley E, Elefanty A, Tobin M, et al. Fourier transform infrared microspectroscopy reveals unique phenotypes for human embryonic and induced pluripotent stem cell lines and their progeny. J Biophotonics. 2014;7:767-81 pubmed publisher
Haupt S, Grützner J, Thier M, Kallweit T, Rath B, Laufenberg I, et al. Automated selection and harvesting of pluripotent stem cell colonies. Biotechnol Appl Biochem. 2012;59:77-87 pubmed publisher
Heng B, Heinimann K, Miny P, Iezzi G, Glatz K, Scherberich A, et al. mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient. Metab Eng. 2013;18:9-24 pubmed publisher
Liu Y, Yang J, Lu Y, Yu P, Dove C, Hutcheson J, et al. ?-1,3-Galactosyltransferase knockout pig induced pluripotent stem cells: a cell source for the production of xenotransplant pigs. Cell Reprogram. 2013;15:107-16 pubmed publisher
Cherry A, Gagne K, McLoughlin E, Baccei A, Gorman B, Hartung O, et al. Induced pluripotent stem cells with a mitochondrial DNA deletion. Stem Cells. 2013;31:1287-97 pubmed publisher
Szablowska Gadomska I, Sypecka J, Zayat V, Podobinska M, Pastwińska A, Pienkowska Grela B, et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. Acta Neurobiol Exp (Wars). 2012;72:337-50 pubmed
Pirozhkova I, Barat A, Dmitriev P, Kim E, Robert T, Guégan J, et al. Differences in transcription patterns between induced pluripotent stem cells produced from the same germ layer are erased upon differentiation. PLoS ONE. 2013;8:e53033 pubmed publisher
Park J, Kim H, Uh K, Choi K, Kim H, Lee T, et al. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig. PLoS ONE. 2013;8:e52481 pubmed publisher
Kanafi M, Pal R, Gupta P. Phenotypic and functional comparison of optimum culture conditions for upscaling of dental pulp stem cells. Cell Biol Int. 2013;37:126-36 pubmed publisher
Chang W, Lavoie J, Kwon S, Chen Z, Manias J, Behbahani J, et al. Feeder-independent derivation of induced-pluripotent stem cells from peripheral blood endothelial progenitor cells. Stem Cell Res. 2013;10:195-202 pubmed publisher
Terrenoire C, Wang K, Tung K, Chung W, Pass R, Lu J, et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol. 2013;141:61-72 pubmed publisher
Lee M, Prasain N, Chae H, Kim Y, Mantel C, Yoder M, et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells. 2013;31:666-81 pubmed publisher
Deng F, Hu H, Chen M, Sun X, Liu X, Dong Z, et al. Generation of induced pluripotent stem cells from human Tenon's capsule fibroblasts. Mol Vis. 2012;18:2871-81 pubmed
Briggs J, Sun J, Shepherd J, Ovchinnikov D, Chung T, Nayler S, et al. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells. 2013;31:467-78 pubmed publisher
Vitale A, Matigian N, Ravishankar S, Bellette B, Wood S, Wolvetang E, et al. Variability in the generation of induced pluripotent stem cells: importance for disease modeling. Stem Cells Transl Med. 2012;1:641-50 pubmed publisher
Nayler S, Gatei M, Kozlov S, Gatti R, Mar J, Wells C, et al. Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem Cells Transl Med. 2012;1:523-35 pubmed publisher
Kudva Y, Ohmine S, Greder L, Dutton J, Armstrong A, De Lamo J, et al. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med. 2012;1:451-61 pubmed publisher
Shah S, Kerr C, Cope L, Zambidis E, Liu C, Hillion J, et al. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. PLoS ONE. 2012;7:e48533 pubmed publisher
Sequiera G, Mehta A, Ooi T, Shim W. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sci. 2013;92:63-71 pubmed publisher
Boucherie C, Mukherjee S, Henckaerts E, Thrasher A, Sowden J, Ali R. Brief report: self-organizing neuroepithelium from human pluripotent stem cells facilitates derivation of photoreceptors. Stem Cells. 2013;31:408-14 pubmed publisher
Beers J, Gulbranson D, George N, Siniscalchi L, Jones J, Thomson J, et al. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc. 2012;7:2029-40 pubmed publisher
Yang J, Mumaw J, Liu Y, Stice S, West F. SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells. Cell Transplant. 2013;22:945-59 pubmed publisher
Lu H, Yang Y, Chen S, Su H, Huang P, Tsai M, et al. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells. Exp Cell Res. 2013;319:498-505 pubmed publisher
Zhou J, Wang X, Zhang S, Gu Y, Yu L, Wu J, et al. Generation and characterization of human cryptorchid-specific induced pluripotent stem cells from urine. Stem Cells Dev. 2013;22:717-25 pubmed publisher
Brosnan K, Want A, Coopman K, Hewitt C. Multiparameter flow cytometry for the characterization of human embryonic stem cells. Biotechnol Lett. 2013;35:55-65 pubmed publisher
Chen A, Lee Y, Hou D, Fong S, Peng Q, Pang R, et al. Study of transforming growth factor alpha for the maintenance of human embryonic stem cells. Cell Tissue Res. 2012;350:289-303 pubmed publisher
Frank S, Zhang M, Scholer H, Greber B. Small molecule-assisted, line-independent maintenance of human pluripotent stem cells in defined conditions. PLoS ONE. 2012;7:e41958 pubmed publisher
Peng Y, Bocker M, Holm J, Toh W, Hughes C, Kidwai F, et al. Human fibroblast matrices bio-assembled under macromolecular crowding support stable propagation of human embryonic stem cells. J Tissue Eng Regen Med. 2012;6:e74-86 pubmed publisher
Chaddah R, Arntfield M, Runciman S, Clarke L, van der Kooy D. Clonal neural stem cells from human embryonic stem cell colonies. J Neurosci. 2012;32:7771-81 pubmed publisher
Zwi Dantsis L, Huber I, Habib M, Winterstern A, Gepstein A, Arbel G, et al. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. Eur Heart J. 2013;34:1575-86 pubmed publisher
Liu X, Wu Y, Li Z, Yang J, Xue J, Hu Y, et al. Targeting of the human coagulation factor IX gene at rDNA locus of human embryonic stem cells. PLoS ONE. 2012;7:e37071 pubmed publisher
Wu D, Seita Y, Zhang X, Lu C, Roth M. Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells. PLoS ONE. 2012;7:e34778 pubmed publisher
Ge X, Wang I, Toma I, Sebastiano V, Liu J, Butte M, et al. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells. Stem Cells Dev. 2012;21:2798-808 pubmed publisher
Harkness L, Kassem M. Procedures for derivation and characterisation of human embryonic stem cells from Odense, Denmark. Methods Mol Biol. 2012;873:33-51 pubmed publisher
Sandt C, Feraud O, Oudrhiri N, Bonnet M, Meunier M, Valogne Y, et al. Identification of spectral modifications occurring during reprogramming of somatic cells. PLoS ONE. 2012;7:e30743 pubmed publisher
Mou X, Wu Y, Cao H, Meng Q, Wang Q, Sun C, et al. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome. Stem Cell Res Ther. 2012;3:14 pubmed publisher
Griscelli F, Feraud O, Oudrhiri N, Gobbo E, Casal I, Chomel J, et al. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. Am J Pathol. 2012;180:2084-96 pubmed publisher
Kozhich O, Hamilton R, Mallon B. Standardized generation and differentiation of neural precursor cells from human pluripotent stem cells. Stem Cell Rev. 2013;9:531-6 pubmed publisher
Polak U, Hirsch C, Ku S, GOTTESFELD J, Dent S, Napierala M. Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts. J Vis Exp. 2012;: pubmed publisher
Pekkanen Mattila M, Ojala M, Kerkela E, Rajala K, Skottman H, Aalto Setala K. The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells. Stem Cells Int. 2012;2012:875059 pubmed publisher
Wang Y, Zheng C, Jiang Y, Zhang J, Chen J, Yao C, et al. Genetic correction of ?-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res. 2012;22:637-48 pubmed publisher
Wang Q, Mou X, Cao H, Meng Q, Ma Y, Han P, et al. A novel xeno-free and feeder-cell-free system for human pluripotent stem cell culture. Protein Cell. 2012;3:51-9 pubmed publisher
Zou C, Chou B, Dowey S, Tsang K, Huang X, Liu C, et al. Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines. Stem Cells Dev. 2012;21:2298-311 pubmed publisher
Jang J, Yoo J, Lee J, Lee D, Kim J, Huh Y, et al. Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. Exp Mol Med. 2012;44:202-13 pubmed publisher
Ji J, Ng S, Sharma V, Neculai D, Hussein S, Sam M, et al. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells. 2012;30:435-40 pubmed publisher
Tra T, Gong L, Kao L, Li X, Grandela C, Devenish R, et al. Autophagy in human embryonic stem cells. PLoS ONE. 2011;6:e27485 pubmed publisher
Ohmine S, Dietz A, Deeds M, Hartjes K, Miller D, Thatava T, et al. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Res Ther. 2011;2:46 pubmed publisher
Silk K, Silk J, Ichiryu N, Davies T, Nolan K, Leishman A, et al. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. Gene Ther. 2012;19:1035-40 pubmed publisher
Heng B, Li J, Chen A, Reuveny S, Cool S, Birch W, et al. Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev. 2012;21:1701-15 pubmed publisher
SHERIDAN S, Theriault K, Reis S, Zhou F, Madison J, Daheron L, et al. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE. 2011;6:e26203 pubmed publisher
Lu Y, West F, Jordan B, Mumaw J, Jordan E, Gallegos Cárdenas A, et al. Avian-induced pluripotent stem cells derived using human reprogramming factors. Stem Cells Dev. 2012;21:394-403 pubmed publisher
Wang Y, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite R, et al. Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res. 2011;21:1551-63 pubmed publisher
Serra M, Correia C, Malpique R, Brito C, Jensen J, Bjorquist P, et al. Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS ONE. 2011;6:e23212 pubmed publisher
Woltjen K, Hamalainen R, Kibschull M, Mileikovsky M, Nagy A. Transgene-free production of pluripotent stem cells using piggyBac transposons. Methods Mol Biol. 2011;767:87-103 pubmed publisher
Prigione A, Lichtner B, Kuhl H, Struys E, Wamelink M, Lehrach H, et al. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells. 2011;29:1338-48 pubmed publisher
Kang N, Yun S, Ha H, Park S, Chang Y. Embryonic and induced pluripotent stem cell staining and sorting with the live-cell fluorescence imaging probe CDy1. Nat Protoc. 2011;6:1044-52 pubmed publisher
Fan J, Robert C, Jang Y, Liu H, Sharkis S, Baylin S, et al. Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining. Mutat Res. 2011;713:8-17 pubmed publisher
Ohnishi H, Oda Y, Aoki T, Tadokoro M, Katsube Y, Ohgushi H, et al. A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2012;6:261-71 pubmed publisher
MacArthur C, Xue H, Van Hoof D, Lieu P, Dudas M, Fontes A, et al. Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev. 2012;21:191-205 pubmed publisher
Lu H, Tsai M, Yang Y, Yuan C, Wang T, Lin X, et al. Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system. Exp Cell Res. 2011;317:1895-903 pubmed publisher
Deleidi M, Hargus G, Hallett P, Osborn T, Isacson O. Development of histocompatible primate-induced pluripotent stem cells for neural transplantation. Stem Cells. 2011;29:1052-63 pubmed publisher
Zhong B, Watts K, Gori J, Wohlfahrt M, Enssle J, Adair J, et al. Safeguarding nonhuman primate iPS cells with suicide genes. Mol Ther. 2011;19:1667-75 pubmed publisher
Fu X, Toh W, Liu H, Lu K, Li M, Cao T. Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system. Tissue Eng Part C Methods. 2011;17:927-37 pubmed publisher
Seibler P, Graziotto J, Jeong H, Simunovic F, Klein C, Krainc D. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci. 2011;31:5970-6 pubmed publisher
Ho J, Zhou T, Lai W, Huang Y, Chan Y, Li X, et al. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY). 2011;3:380-90 pubmed
Wada N, Wang B, Lin N, Laslett A, Gronthos S, Bartold P. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J Periodontal Res. 2011;46:438-47 pubmed publisher
Pringle S, De Bari C, Dell accio F, Przyborski S, Cooke M, Minger S, et al. Mesenchymal differentiation propensity of a human embryonic stem cell line. Cell Prolif. 2011;44:120-7 pubmed publisher
Krtolica A, Larocque N, Genbacev O, Ilic D, Coppe J, Patil C, et al. GROα regulates human embryonic stem cell self-renewal or adoption of a neuronal fate. Differentiation. 2011;81:222-32 pubmed publisher
Kim J, Moon S, Lee S, Cho Y, Hong K, Lee J, et al. Assessment of differentiation aspects by the morphological classification of embryoid bodies derived from human embryonic stem cells. Stem Cells Dev. 2011;20:1925-35 pubmed publisher
MacIntyre D, Melguizo Sanchís D, Jimenez B, Moreno R, Stojkovic M, Pineda Lucena A. Characterisation of human embryonic stem cells conditioning media by 1H-nuclear magnetic resonance spectroscopy. PLoS ONE. 2011;6:e16732 pubmed publisher
Li Y, Cang M, Lee A, Zhang K, Liu D. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS ONE. 2011;6:e15947 pubmed publisher
Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, et al. Generation of human melanocytes from induced pluripotent stem cells. PLoS ONE. 2011;6:e16182 pubmed publisher
Natunen S, Satomaa T, Pitkänen V, Salo H, Mikkola M, Natunen J, et al. The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope. Glycobiology. 2011;21:1125-30 pubmed publisher
Tolar J, Xia L, Riddle M, Lees C, Eide C, McElmurry R, et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2011;131:848-56 pubmed publisher
Wang Y, Adjaye J. A cyclic AMP analog, 8-Br-cAMP, enhances the induction of pluripotency in human fibroblast cells. Stem Cell Rev. 2011;7:331-41 pubmed publisher
Zhong B, Trobridge G, Zhang X, Watts K, Ramakrishnan A, Wohlfahrt M, et al. Efficient generation of nonhuman primate induced pluripotent stem cells. Stem Cells Dev. 2011;20:795-807 pubmed publisher
Thatava T, Nelson T, Edukulla R, Sakuma T, Ohmine S, Tonne J, et al. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther. 2011;18:283-93 pubmed publisher
Fujioka T, Shimizu N, Yoshino K, Miyoshi H, Nakamura Y. Establishment of induced pluripotent stem cells from human neonatal tissues. Hum Cell. 2010;23:113-8 pubmed publisher
Yang J, Cai J, Zhang Y, Wang X, Li W, Xu J, et al. Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem. 2010;285:40303-11 pubmed publisher
O Leary T, Heindryckx B, Lierman S, Van der Jeught M, Menten B, Deforce D, et al. The influence of early embryo traits on human embryonic stem cell derivation efficiency. Stem Cells Dev. 2011;20:785-93 pubmed publisher
Hammerick K, Huang Z, Sun N, Lam M, Prinz F, Wu J, et al. Elastic properties of induced pluripotent stem cells. Tissue Eng Part A. 2011;17:495-502 pubmed publisher
Liu J, Sumer H, Leung J, Upton K, Dottori M, Pebay A, et al. Late passage human fibroblasts induced to pluripotency are capable of directed neuronal differentiation. Cell Transplant. 2011;20:193-203 pubmed publisher
Somers A, Jean J, Sommer C, Omari A, Ford C, Mills J, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells. 2010;28:1728-40 pubmed publisher
Gao X, Yan J, Shen Y, Li M, Ma S, Wang J, et al. Human fetal trophonema matrix and uterine endometrium support better human embryonic stem cell growth and neural differentiation than mouse embryonic fibroblasts. Cell Reprogram. 2010;12:295-303 pubmed publisher
Li Y, Zhao H, Lan F, Lee A, Chen L, Lin C, et al. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG. Cell Reprogram. 2010;12:237-47 pubmed publisher
Leung H, Chen A, Choo A, Reuveny S, Oh S. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods. 2011;17:165-72 pubmed publisher
Macias M, Grande J, Moreno A, Dominguez I, Bornstein R, Flores A. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Am J Obstet Gynecol. 2010;203:495.e9-495.e23 pubmed publisher
Tomioka I, Maeda T, Shimada H, Kawai K, Okada Y, Igarashi H, et al. Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes Cells. 2010;15:959-69 pubmed publisher
Melkoumian Z, Weber J, Weber D, Fadeev A, Zhou Y, Dolley Sonneville P, et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol. 2010;28:606-10 pubmed publisher
Liu H, Ye Z, Kim Y, Sharkis S, Jang Y. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology. 2010;51:1810-9 pubmed publisher
Villa Diaz L, Garcia Perez J, Krebsbach P. Enhanced transfection efficiency of human embryonic stem cells by the incorporation of DNA liposomes in extracellular matrix. Stem Cells Dev. 2010;19:1949-57 pubmed publisher
Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells. 2010;28:721-33 pubmed publisher
Terstegge S, Winter F, Rath B, Laufenberg I, Schwarz C, Leinhaas A, et al. Laser-assisted photoablation of human pluripotent stem cells from differentiating cultures. Stem Cell Rev. 2010;6:260-9 pubmed publisher
Sidhu K, Ryan J, Lees J, Tuch B. Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization. In Vitro Cell Dev Biol Anim. 2010;46:269-75 pubmed publisher
Lagarkova M, Eremeev A, Svetlakov A, Rubtsov N, Kiselev S. Human embryonic stem cell lines isolation, cultivation, and characterization. In Vitro Cell Dev Biol Anim. 2010;46:284-93 pubmed publisher
Skottman H. Derivation and characterization of three new human embryonic stem cell lines in Finland. In Vitro Cell Dev Biol Anim. 2010;46:206-9 pubmed publisher
Jia F, Wilson K, Sun N, Gupta D, Huang M, Li Z, et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods. 2010;7:197-9 pubmed publisher
Cai J, Li W, Su H, Qin D, Yang J, Zhu F, et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem. 2010;285:11227-34 pubmed publisher
Li T, Mai Q, Gao J, Zhou C. Cryopreservation of human embryonic stem cells with a new bulk vitrification method. Biol Reprod. 2010;82:848-53 pubmed publisher
Heraud P, Ng E, Caine S, Yu Q, Hirst C, Mayberry R, et al. Fourier transform infrared microspectroscopy identifies early lineage commitment in differentiating human embryonic stem cells. Stem Cell Res. 2010;4:140-7 pubmed publisher
Shimozawa N, Nakamura S, Takahashi I, Hatori M, Sankai T. Characterization of a novel embryonic stem cell line from an ICSI-derived blastocyst in the African green monkey. Reproduction. 2010;139:565-73 pubmed publisher
Huan Q, Gao X, Wang Y, Shen Y, Ma W, Chen Z. Comparative evaluation of human embryonic stem cell lines derived from zygotes with normal and abnormal pronuclei. Dev Dyn. 2010;239:425-38 pubmed publisher
Takenaka C, Nishishita N, Takada N, Jakt L, Kawamata S. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol. 2010;38:154-62 pubmed publisher
Fathi A, Pakzad M, Taei A, Brink T, Pirhaji L, Ruiz G, et al. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body-based differentiation. Proteomics. 2009;9:4859-70 pubmed publisher
Rowland T, Miller L, Blaschke A, Doss E, Bonham A, Hikita S, et al. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev. 2010;19:1231-40 pubmed publisher
Sun N, Panetta N, Gupta D, Wilson K, Lee A, Jia F, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A. 2009;106:15720-5 pubmed publisher
Ye Z, Zhan H, Mali P, Dowey S, Williams D, Jang Y, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood. 2009;114:5473-80 pubmed publisher
Byrne J, Nguyen H, Reijo Pera R. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS ONE. 2009;4:e7118 pubmed publisher
Hannan N, Jamshidi P, Pera M, Wolvetang E. BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures. Cloning Stem Cells. 2009;11:427-35 pubmed publisher
Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Puceat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol. 2009;186:665-73 pubmed publisher
Kim J, Greber B, Arauzo Bravo M, Meyer J, Park K, Zaehres H, et al. Direct reprogramming of human neural stem cells by OCT4. Nature. 2009;461:649-3 pubmed publisher
Mitsui K, Suzuki K, Aizawa E, Kawase E, Suemori H, Nakatsuji N, et al. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors. Biochem Biophys Res Commun. 2009;388:711-7 pubmed publisher
Geens M, Mateizel I, Sermon K, De Rycke M, Spits C, Cauffman G, et al. Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod. 2009;24:2709-17 pubmed publisher
Camarasa M, Brison D, Kimber S, Handyside A. Naturally immortalised mouse embryonic fibroblast lines support human embryonic stem cell growth. Cloning Stem Cells. 2009;11:453-62 pubmed publisher
Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod. 2009;24:2477-89 pubmed publisher
Dang D, Ramos D. Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma. Anticancer Res. 2009;29:2043-9 pubmed
Ilic D, Caceres E, Lu S, Julian P, Foulk R, Krtolica A. Effect of karyotype on successful human embryonic stem cell derivation. Stem Cells Dev. 2010;19:39-46 pubmed publisher
Ye L, Chang J, Lin C, Sun X, Yu J, Kan Y. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A. 2009;106:9826-30 pubmed publisher
Butler J, Hall L, Smith K, Lawrence J. Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells. J Cell Biochem. 2009;107:609-21 pubmed publisher
Nagase T, Ueno M, Matsumura M, Muguruma K, Ohgushi M, Kondo N, et al. Pericellular matrix of decidua-derived mesenchymal cells: a potent human-derived substrate for the maintenance culture of human ES cells. Dev Dyn. 2009;238:1118-30 pubmed publisher
Nasrabadi D, Rezaei Larijani M, Pirhaji L, Gourabi H, Shahverdi A, Baharvand H, et al. Proteomic analysis of monkey embryonic stem cell during differentiation. J Proteome Res. 2009;8:1527-39 pubmed publisher
Seol H, Oh S, Park Y, Kim H, Baek J, Seo J, et al. Separation and maintenance of normal cells from human embryonic stem cells with trisomy 12 mosaicism. Chromosome Res. 2008;16:1075-84 pubmed publisher
Tateishi K, He J, Taranova O, Liang G, D Alessio A, Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem. 2008;283:31601-7 pubmed publisher
Ueda S, Kawamata M, Teratani T, Shimizu T, Tamai Y, Ogawa H, et al. Establishment of rat embryonic stem cells and making of chimera rats. PLoS ONE. 2008;3:e2800 pubmed publisher
Park I, Zhao R, West J, Yabuuchi A, Huo H, Ince T, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141-6 pubmed
Dravid G, Hammond H, Cheng L. Culture of human embryonic stem cells on human and mouse feeder cells. Methods Mol Biol. 2006;331:91-104 pubmed
product information
Catalog Number :
FCMAB115F
Subcategory :
Stem Cell Research
Product Name :
Anti-TRA-1-60 Antibody, clone TRA-1-60, FITC conjugate
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Host Name :
Mouse
Antigen :
TRA-1-60
Clone :
TRA-1-60
Conjugate :
FITC
Isotype :
IgM
Product Description :
Anti-TRA-1-60 Antibody, clone TRA-1-60, FITC conjugate
Cross Reactivity :
Human
Background :
Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and α-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or α-fetoprotein.
Immunogen :
- Whole Cells corresponding to the of TRA-1-60.
Specificity :
This antibody reacts with TRA-1-60 antigen that is expressed upon the surface of human tetracarcinoma stem cells (EC), human embryonic germ cells (EG) and human embryonic stem cells (ES). No immunoreactivity is seen with murine EC, EG, or ES cells. Both the TRA-1-60 and TRA-1-81 monoclonal antibodies (MAB4381) recognize antigens that are associated with a pericellular matrix proteoglycan. TRA-1-60 reacts with a sialidase-sensitive epitope whilst TRA-1-81 reacts with an unknown epitope of the same molecule
Package Size :
100 tests
Uses :
Flow Cytometry;Immunocytochemistry
Storage :
Maintain refrigerated at 2-8ºC protected from light in undiluted aliquots for up to 6 months from date of receipt.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com
888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany

Hundreds of New Antibodies in the areas of:
  • • Cancer
  • • Nuclear Signaling
  • • Apoptosis
  • • Cardiovascular Disease
  • • Developmental Biology
  • • Metabolic Disease
  • • Neurodegenerative Disease
  • • Cell Biology
View all the new antibodies at www.emdmillipore.com.